Calendar Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 18/07/2025 BST			5-day change	1st Jan Change
16.76 ^USD	-11.09%		-8.47%	-10.85%

07-08	Arrowhead Pharmaceuticals, Inc., Q2 2025 Earnings Call, May 12, 2025
07-08	Arrowhead Pharmaceuticals Initiates Phase 3 YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia	CI

Chart calendar Arrowhead Pharmaceuticals, Inc.

af945bc8220b2a3ef341e919abc287.HXaQBHurJ0EzOueb6TBCXubOx31yOMRI6zNNAzr_P1E.UDq9VTrKU3V-e97Mmll3c5D_oR8ZSqAruVIodG-GZyNzKdhNTOpwFQBs0w~c682567b0c0bfc27cf5c0868657f713b

Upcoming events on Arrowhead Pharmaceuticals, Inc.

10/08/2025	Q3 2025 Earnings Release (Projected)
30/11/2025	Q4 2025 Earnings Release (Projected)
09/02/2026	Q1 2026 Earnings Release (Projected)
06/05/2026	Q2 2026 Earnings Release (Projected)

Past events on Arrowhead Pharmaceuticals, Inc.

16/06/2025	H.C. Wainwright Neuro Perspectives Hybrid Conference
09/06/2025 19:00	Goldman Sachs Global Healthcare Conference
04/06/2025 14:20	Jefferies Healthcare Conference
28/05/2025	National Lipid Association Scientific Conference
20/05/2025 19:35	RBC Global Healthcare Conference - Fireside Chat
18/05/2025	TIDES USA Conference
14/05/2025 19:20	Bank of America Global Healthcare Conference - Fireside Chat
12/05/2025 21:30	Q2 2025 Earnings Call
12/05/2025 21:01	Q2 2025 Earnings Release
10/05/2025	European Obesity Congress
07/05/2025 11:00	European Atherosclerosis Society Congress
05/05/2025 13:30	European Atherosclerosis Society Congress
12/03/2025 17:00	Annual General Meeting
05/03/2025	RNA Leaders Congress
03/03/2025 14:50	TD Cowen Healthcare Conference
10/02/2025 21:30	Q1 2025 Earnings Call
10/02/2025 21:01	Q1 2025 Earnings Release
13/12/2024 15:30	World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
11/12/2024 15:00	Complement-Based Drug Development Summit
11/12/2024 00:30	Global CVCT Forum

Annual results

Fiscal Period	September	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	243 294 -17.16%	241 264 -8.67%	3,55 61,6 -94.24%	698	286	297
EBITDA Million USD	Released Forecast Spread	-168 -87,9 -91.14%	-193 -159 -21.17%	-582 -536 -8.69%	-8,68	-393	-553
EBIT Million USD	Released Forecast Spread	-179 -135 -32.5%	-205 -162 -26.6%	-601 -557 -7.95%	32,3	-451	-495
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-173 -149 -16.06%	-206 -159 -29.54%	-612 -552 -10.94%	28,8	-511	-433
Net income Million USD	Released Forecast Spread	-176 -149 -18.32%	-205 -151 -36.13%	-599 -535 -11.97%	36,6	-469	-433
EPS USD	Released Forecast Spread	-1,67 -1,46 -14.41%	-1,92 -1,51 -26.73%	-5,00 -4,52 -10.67%	0,19	-3,37	-3,10
Announcement Date		28/11/22	29/11/23	26/11/24	-

Quarterly results

Fiscal Period	March	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	16,1 47,0 -65.73%	3,55 29,6 -88.02%	0,00 56,8 -	0,00 37,1 -	0,00 58,9 -	2,50 19,1 -86.88%	543 116 366.77%	29,0	116	128	31,4	31,0	69,1
EBITDA Million USD	Released Forecast Spread	-104 -93,1 -12.21%	-132 -101 -31.23%	-122 -86,9 -39.99%	-171 -0,80 -21319.88%	-157 -134 -17.65%			-144	-153
EBIT Million USD	Released Forecast Spread	-108 -67,2 -61.28%	-137 -98,0 -39.38%	-126 -42,3 -198.14%	-176 -76,2 -131.05%	-162 -121 -34.53%	-161 -148 -8.76%	381 -50,2 859.27%	-136	-60,3	-69,6	-155	-148	-143
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-109 -60,4 -80.54%	-139 -101 -37.1%	-127 -38,4 -230.34%	-174 -80,1 -117.22%	-173 -102 -69.53%	-175 -145 -20.88%	370 16,5 2137.84%	-135	-60,1	-100	-165	-154	-149
Net income Million USD	Released Forecast Spread	-110 -52,2 -110.22%	-133 -88,1 -50.76%	-125 -15,6 -705.53%	-171 -72,0 -137.12%	-171 -97,0 -75.83%	-173 -139 -24.41%	370 -12,5 3072.48%	-137	-45,0	-100	-165	-154	-149
EPS USD	Released Forecast Spread	-1,02 -0,58 -75.41%	-1,24 -0,81 -54.01%	-1,02 -0,22 -369.12%	-1,38 -0,57 -140.61%	-1,37 -0,87 -57.26%	-1,39 -0,38 -264.59%	2,75 0,01 34189.28%	-0,99	-0,32	-0,63	-1,25	-1,21	-0,97
Announcement Date		29/11/23	06/02/24	09/05/24	08/08/24	26/11/24	10/02/25	12/05/25	-	-	-	-	-	-

Upcoming sector events for Arrowhead Pharmaceuticals, Inc.

22/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release
27/07/2025	EXELIXIS, INC.: Q2 2025 Earnings Release
27/07/2025	WUXI APPTEC CO., LTD.: Q2 2025 Earnings Release
29/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	INSMED INCORPORATED: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Arrowhead Pharmaceuticals, Inc.

10/07/2025 12:00	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release
10/07/2025 08:10	LUMOSA THERAPEUTICS CO., LTD.: June 2025 Sales and Revenue Release
09/07/2025 21:01	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release
07/07/2025 17:00	TAIMED BIOLOGICS INC.: June 2025 Sales and Revenue Release
05/07/2025 03:24	PHARMAESSENTIA CORPORATION: June 2025 Sales and Revenue Release
12/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 07:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
05/06/2025 08:46	TAIMED BIOLOGICS INC.: May 2025 Sales and Revenue Release
15/05/2025 13:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release